Price Alert

Fennec Pharmaceuticals In... (FENC)

NASDAQ: FENC · Real-Time Price · USD

8.39

-0.14 (-1.64%)

At close: Aug 15, 2025, 3:59 PM

8.36

-0.36%

After-hours: Aug 15, 2025, 04:10 PM EDT

Fennec Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	22.68M	26.63M	40.32M	43.05M	51.13M	13.2M	12.4M	14.96M	18.39M	23.77M	29.75M	14.91M	18.26M	21.1M	24.34M	27.29M	26.75M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.43M	822K	956K	988.85K	1.02M	5.97K	53.14K	106K	159K	211K	264K	14K	21K	27K	35K	41K	n/a
Receivables	18.08M	12.88M	12.91M	12.31M	10.27M	8.81M	4.53M	2.44M	1.68M	1.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	1.4M	1.06M	1.13M	2.14M	2.06M	2.14M	1.75M	1.44M	918K	576K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	814K	465.72K	546K	283K	161K	44K	20K	32K	32K	63K	123K	149K	154K	253K	412K	372K	455K
Total Current Assets	42.98M	44.12M	57.97M	62.16M	68.1M	26.72M	18.95M	19.33M	21.66M	26.73M	30.15M	15.55M	19.13M	22.39M	25.98M	28.07M	27.82M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	28.86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.43M	822K	956K	988.85K	1.02M	5.97K	82K	106K	159K	211K	264K	14K	21K	27K	35K	41K	n/a
Total Assets	46.4M	44.95M	58.92M	63.15M	69.12M	26.73M	19.03M	19.44M	21.82M	26.94M	30.42M	15.57M	19.15M	22.41M	26.01M	28.11M	27.82M
Account Payables	5.28M	2.88M	3.87M	4.45M	5.2M	3.78M	2.94M	3M	2.95M	2.39M	2.53M	1.74M	1.22M	777K	1.15M	677K	2.51M
Deferred Revenue	n/a	247.85K	247.61K	251.96K	251.74K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	364.15K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	500K	n/a	n/a	n/a	n/a
Other Current Liabilities	3.09M	366.15K	n/a	252K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	8.37M	6.92M	7.43M	7.75M	9.83M	7.51M	3.91M	3.78M	4.02M	4.61M	2.93M	3.04M	2.14M	1.65M	2.01M	848K	2.89M
Long-Term Debt	n/a	19.34M	32.1M	29.75M	29.7M	29.56M	25.64M	25.39M	25.14M	24.9M	24.69M	3.99M	4.49M	4.99M	4.99M	4.99M	n/a
Other Long-Term Liabilities	35.54M	24.56M	2.32M	2.03M	1.65M	1.37M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	35.54M	43.9M	56.66M	56.76M	56.28M	30.77M	25.65M	25.39M	25.14M	24.9M	24.69M	3.99M	4.49M	4.99M	4.99M	4.99M	2.51M
Total Liabilities	43.91M	50.82M	64.09M	64.51M	66.11M	38.29M	29.56M	29.16M	29.16M	29.51M	27.61M	7.03M	6.63M	6.64M	7M	5.83M	2.89M
Total Debt	n/a	19.34M	32.1M	29.76M	29.72M	29.58M	25.67M	25.39M	25.14M	24.9M	24.69M	4.99M	4.99M	4.99M	4.99M	4.99M	n/a
Common Stock	145.98M	145.61M	145.44M	145.26M	144.78M	143.57M	143.56M	143.34M	142.8M	142.59M	141.31M	140.92M	140.83M	140.8M	140.78M	140.78M	140.73M
Retained Earnings	-220.85M	-219.31M	-217.7M	-211.93M	-206.2M	-218.12M	-216.56M	-214.7M	-209.25M	-203.2M	-196.34M	-188.25M	-183.18M	-179.49M	-175.06M	-170.87M	-166.87M
Comprehensive Income	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M	1.24M
Shareholders Equity	2.49M	-5.51M	-5.17M	-1.36M	3.01M	-11.56M	-10.53M	-9.73M	-7.34M	-2.57M	2.8M	8.54M	12.52M	15.77M	19.01M	22.28M	24.93M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a